Macro close-up of microscopic cellular microalgae structures, glowing with subtle emerald and deep teal bioluminescence under cool, crisp laboratory light, sterile white background, 50mm.
Macro close-up of microscopic cellular microalgae structures, glowing with subtle emerald and deep teal bioluminescence under cool, crisp laboratory light, sterile white background, 50mm.
Inquire about licensing
View technical specs
DEVELOPMENT PIPELINE

Bioactive compounds with molecular purity.

We program specific microalgae strains in closed-loop photobioreactors, delivering scalable, carbon-negative chemical profiles for oncology and metabolic therapeutics.

Macro close-up of crystalline carotenoid structures under a microscope, deep green and teal hues, crisp laboratory lighting, sterile background.
Macro close-up of crystalline carotenoid structures under a microscope, deep green and teal hues, crisp laboratory lighting, sterile background.
Microscopic view of polar lipid vesicles, emerald bioluminescent edges, cool white laboratory backdrop, high-magnification.
Microscopic view of polar lipid vesicles, emerald bioluminescent edges, cool white laboratory backdrop, high-magnification.
Fluorescent phycobilin proteins glowing bright cyan and emerald under ultraviolet laboratory light, scientific macro photography.
Fluorescent phycobilin proteins glowing bright cyan and emerald under ultraviolet laboratory light, scientific macro photography.
CLINICAL & INDUSTRIAL PORTFOLIO

Active Pipeline Candidates

VX-702 Carotenoid

VX-910 Lipids

VX-415 Phycobilin

High-purity antioxidant compound engineered for oncology therapeutic formulations. Replaces synthetic petroleum-derived equivalents with consistent batch profiles.

Complex polar lipids optimized for metabolic health applications and advanced drug delivery systems. Synthesized via closed-loop carbon capture with minimal footprint.

Bioluminescent fluorescent markers designed for diagnostic assays and research reagents. Cultured in sterile, clinical-grade photobioreactors to guarantee consistent molecular profiles.

A clinical researcher in sterile cleanroom gear operating an analytical mass spectrometer, cool laboratory light with subtle green bioluminescence, 50mm.
A clinical researcher in sterile cleanroom gear operating an analytical mass spectrometer, cool laboratory light with subtle green bioluminescence, 50mm.
SYNTHESIS STANDARDS

Clinical-grade molecular purity

We cultivate specific microalgae strains in closed, sterile photobioreactors to yield precise molecular profiles. Our automated platform eliminates environmental variability, delivering consistent batch profiles that meet rigorous pharmaceutical requirements.

TECHNICAL INQUIRIES

Frequently Asked Questions

How do you guarantee batch consistency?

What is the carbon footprint of your platform?

By utilizing closed, sterile photobioreactors with automated environmental controls, we eliminate the weather and contamination risks of open-pond harvesting.

Our closed-loop system captures more carbon dioxide during photosynthesis than is emitted during extraction, achieving a net-negative CO2e footprint.

How do licensing agreements work?

Are your compounds compatible with pharma pipelines?

We offer flexible co-development and exclusive licensing models for therapeutic candidates, backed by complete analytical validation packages.

Our bioactive molecules are synthesized to match or exceed USP/EP standards, ensuring direct integration into existing formulation workflows.

Inquire about licensing

Accelerate your pipeline.

Partner with Valgogenix to secure clinical-grade microalgae bioactive molecules and meet your enterprise sustainability targets.